Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous versus intermittent midazolam infusion plus pethidine for sedation in small bowel endoscopy
jRCTs031200018Completed
- Sponsor
- National Hospital Organization
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of midazolam and pethidine in gastrointestinal bleeding, small bowel stenosis, small bowel neoplasm and 1 more (2 arms), sponsored by National Hospital Organization. Primary endpoint: Proper sedation rate. Started Apr 2020; status: completed.
02
Drugs
midazolampethidine
03
Conditions
gastrointestinal bleedingsmall bowel stenosissmall bowel neoplasminflammatory bowel disease (IBD)
Beyond the preview
Go deeper on jRCTs031200018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031200018.